Our Thinking
Articles
- Valuing the Patient Voice in Medicines Access Decisions - How Does Australia Compare?
- Malaysia: The New Destination for Early Phase Trials
- China IIT vs. China IND: When an Investigator Initiated Trial can accelerate early development
- Southeast Asia and Pakistan Overview: The Emerging Hub for Clinical Trial Scale Up
- Pakistan’s Advantage in Hepatitis Delta & MASH Trials
- Philippines: A Growing Strategic Center for Clinical Trials
- India in Focus: Lung Cancer Trial Readiness
- SEA and Pakistan: Emerging Hub for Vaccine Clinical Trials
- Evidence-Based Strategic Differentiation in the APAC Region – WHY Is Integrated Evidence Generation (IEG) Required in APAC?
- Evidence-Based Strategic Differentiation in the APAC Region – WHO Are the Key Stakeholders in IEG?
- Bridging the Divide: Measuring the Impact of the Pharmaceutical Reform Agreements on Medicine Access
- Individual and Community: Exploring the Dynamics of Self-Care in Southeast Asia